ncm-usa.com
NCM USANCM’s strategy is to develop the most advanced PET radiopharmaceutical manufacturing and distribution network in New York State. The American market for molecular imaging agents currently exceeds $1.3 billion annually and is expected to grow to over $3 billion by 2020. Tour our up and coming state-of-the-art manufacturing facility. View a quick presentation of the science behind radio-pharmaceuticals. 461 Park Avenue South. New York, NY 10016.
http://www.ncm-usa.com/